Danaher Corporation (NYSE:DHR) is one of the best strong buy healthcare stocks to invest in. Danaher Corporation (NYSE:DHR) announced on February 24 that its Board of Directors approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026, to holders of record on March 27, 2026. In another development, the company announced on February 17 a definitive agreement to acquire Masimo Corporation, which is a leading specialty diagnostics provider of pulse oximetry a ...

Headquartered in Washington, D.C., Danaher Corporation (DHR) is a global science and technology powerhouse focused on biotechnology, life sciences, and diagnostics. With a market capitalization of nearly $149 billion, it sits in the “large-cap” territory, a space reserved for companies valued above $10 billion. This scale gives Danaher the muscle to build bioprocessing systems, precision laboratory instruments, genomic technologies, and clinical diagnostic platforms that anchor drug development, scientif ...

Danaher Corporation (NYSE:DHR) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 17, Danaher Corporation (NYSE:DHR) announced an agreement to acquire Masimo Corporation (NASDAQ:MASI) for nearly $9.9 billion. In the all-cash deal, Danaher will acquire 100% of the common shares outstanding at $180 per share. This translates into 2027 forecasted EBITDA multiples of 15x and 18x, with and without potential synergies, respectively. All-Cash Masimo Deal Offers Strong Strate ...